HealthPolitics

STAT+: Gilead to pay $45 million to settle kickback charges filed by Texas attorney general

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 22/10/2026, 23:21:25 UTC.

Briefings

Gilead Sciences settled allegations of kickback payments with the Texas Medicaid program by paying $45 million. The state also pursued a separate lawsuit involving a whistleblower who alleged Gilead paid another company to hire registered nurses to prescribe drugs. The Texas Medicaid program is a federal program that covers low-income individuals in Texas, and the settlement resolved marketing practices that improperly influenced prescriptions.

Key points

• Gilead Sciences agreed to pay $45 million to settle allegations of kickback payments that improperly influenced prescriptions paid for by the Texas Medicaid program.
• The Texas Medicaid program is a federal program that covers low-income individuals in Texas, and the settlement resolved marketing practices that improperly influenced prescriptions.

Context

This is a recent development in the pharmaceutical industry, as Gilead Sciences is the latest major pharmaceutical company to reach a deal with the state over marketing practices. The state pursued its claims alongside a whistleblower who also filed a lawsuit claiming Gilead paid another company to hire registered nurses to recommend its drugs.

Limitations

The evidence is limited to the settlement details and the separate whistleblower lawsuit; no specific dates for the nurse hiring allegations are provided, and the exact scope of the nurse hiring allegations remains unclear.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 22/10/2026, 23:22:10 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeicyk7ejt42x6rawlfvtihz5dhlrzaktec3encj5pjnqzidpgxglze